1.Date of occurrence of the change:2023/12/29
2.Name of legal person: OBI Pharma Inc.
3.Name of the previous position holder: Chen-En Tsai
4.Resume of the previous position holder:
Vice president of Medical Division, OBI Pharma Inc.
5.Name of the new position holder: Heidi Wang
6.Resume of the new position holder: CEO, OBI Pharma Inc.
7.Reason for the change: Reassignment
8.Original term (from __________ to __________):2021/10/27~2024/10/26
9.Effective date of the new appointment:2023/12/29
10.Any other matters that need to be specified: None.